Malignant Hematology

The UTHSC Cancer Program has a comprehensive malignant hematology treatment team comprised of hematologists, hemato-pathologists, pharmacists and specialized nursing care. This team coordinates multidisciplinary care with other specialties such as radiation oncology, bone marrow transplant, nutrition and surgery to facilitate diagnosis and the best treatment plans. The hematologists specialize in the treatment of common forms of blood cancers such as acute leukemias, myelodysplastic syndrome, chronic leukemias, myeloma and lymphoma. The team also provides expert care for rare forms of blood disorders such as amyloidosis, T-cell lymphoma/leukemia, histiocytic disorders, aplastic anemia and other bone marrow failure conditions. By application of modern targeted therapies, clinical trial participation opportunities and cancer genome sequencing technology we aim to provide personalized and cutting-edge treatment to our patients in Memphis and the surrounding areas. The UTHSC malignant hematology team prioritizes patient health and wellbeing and provides the best treatment options and key supported care throughout UTHSC and its affiliated hospitals.